Benefits of high-dose, high-frequency interferon beta-1a in...

Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trial

Hillel Panitch, Douglas Goodin, Gordon Francis, Peter Chang, Patricia Coyle, Paul O'Connor, David Li, Brian Weinshenker
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
239
Year:
2005
Language:
english
DOI:
10.1016/j.jns.2005.08.003
File:
PDF, 153 KB
english, 2005
Conversion to is in progress
Conversion to is failed